4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001209191-22-019403
Director acquired 3,496 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2022-03-15 | Option exercise | +3,496 | $1.30 | $4,545 | 7,596 | D |
| Derivatives | |||||||
| Coleman Mark Director | 2022-03-15 | Option exercise · Stock Option (Right to Buy) | −3,496 | 17,501 | D | ||
Loading xslF345X03/doc4.xml…